IPO

Explore the landscape of IPO in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on IPO to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

European Commission Revokes Hansoh's Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute
CompanyDrug

European Commission Revokes Hansoh’s Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

Hansoh Pharmaceutical Group Company Limited (HKG: 3692) announced that the European Commission (EC) has revoked the marketing authorization for Aumolertinib, just seven months after its EU approval in February 2026.…

Merck's Subcutaneous Pembrolizumab Approved by China's NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Merck’s Subcutaneous Pembrolizumab Approved by China’s NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Akeso Biopharma Plans IPO on Shanghai’s STAR Market

CompanyDeals

Luye Pharma’s Shandong Boan Bio Files for Hong Kong IPO

CompanyDeals

3D Medicines Set for IPO in Hong Kong, Aiming to Raise Up to USD 55 Million

CompanyDeals

Visen Pharmaceuticals Files for Hong Kong IPO with Focus on Growth Hormone

CompanyDeals

OrbusNeich Files for IPO on Hong Kong Stock Exchange

CompanyDeals

Jianke.com Files for Hong Kong IPO with Focus on Chronic Disease Management

CompanyDeals

Innovex Medical Files for IPO in Hong Kong to Boost Product Development

CompanyDeals

LEPU ScienTech Medical Technology Sets IPO Price Range Ahead of Hong Kong Listing

Show More